BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

802 related articles for article (PubMed ID: 25593131)

  • 21. Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling.
    Vaiyapuri S; Ali MS; Moraes LA; Sage T; Lewis KR; Jones CI; Gibbins JM
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2740-9. PubMed ID: 24135020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Pharmacodynamic Study of CN-218, a Novel Antiplatelet and Antithrombotic Agent Primarily Targeting the P2Y
    Li X; Liu P; Xu Z; Sun D; Gu J; Miao Y; Zhang J; Cao X
    Cardiovasc Drugs Ther; 2020 Feb; 34(1):15-23. PubMed ID: 32062793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glybenclamide: an antidiabetic with in vivo antithrombotic activity.
    Ting HJ; Khasawneh FT
    Eur J Pharmacol; 2010 Dec; 649(1-3):249-54. PubMed ID: 20858477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RUC-4: a novel αIIbβ3 antagonist for prehospital therapy of myocardial infarction.
    Li J; Vootukuri S; Shang Y; Negri A; Jiang JK; Nedelman M; Diacovo TG; Filizola M; Thomas CJ; Coller BS
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2321-9. PubMed ID: 25147334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A platelet target for venous thrombosis? P2Y1 deletion or antagonism protects mice from vena cava thrombosis.
    Bird JE; Wang X; Smith PL; Barbera F; Huang C; Schumacher WA
    J Thromb Thrombolysis; 2012 Aug; 34(2):199-207. PubMed ID: 22588534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Farnesoid X Receptor and Its Ligands Inhibit the Function of Platelets.
    Moraes LA; Unsworth AJ; Vaiyapuri S; Ali MS; Sasikumar P; Sage T; Flora GD; Bye AP; Kriek N; Dorchies E; Molendi-Coste O; Dombrowicz D; Staels B; Bishop-Bailey D; Gibbins JM
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2324-2333. PubMed ID: 27758768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clopidogrel versus prasugrel in rabbits. Effects on thrombosis, haemostasis, platelet function and response variability.
    Wong PC; Crain EJ; Watson CA; Hua J; Schumacher WA; Rehfuss R
    Thromb Haemost; 2009 Jan; 101(1):108-15. PubMed ID: 19132196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling.
    Irfan M; Jeong D; Kwon HW; Shin JH; Park SJ; Kwak D; Kim TH; Lee DH; Park HJ; Rhee MH
    Vascul Pharmacol; 2018 Oct; 109():45-55. PubMed ID: 29890296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.
    Schwarz M; Meade G; Stoll P; Ylanne J; Bassler N; Chen YC; Hagemeyer CE; Ahrens I; Moran N; Kenny D; Fitzgerald D; Bode C; Peter K
    Circ Res; 2006 Jul; 99(1):25-33. PubMed ID: 16778135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular cyclophilin A activates platelets via EMMPRIN (CD147) and PI3K/Akt signaling, which promotes platelet adhesion and thrombus formation in vitro and in vivo.
    Seizer P; Ungern-Sternberg SN; Schönberger T; Borst O; Münzer P; Schmidt EM; Mack AF; Heinzmann D; Chatterjee M; Langer H; Malešević M; Lang F; Gawaz M; Fischer G; May AE
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):655-63. PubMed ID: 25550208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ticagrelor, but not clopidogrel, reduces arterial thrombosis via endothelial tissue factor suppression.
    Reiner MF; Akhmedov A; Stivala S; Keller S; Gaul DS; Bonetti NR; Savarese G; Glanzmann M; Zhu C; Ruf W; Yang Z; Matter CM; Lüscher TF; Camici GG; Beer JH
    Cardiovasc Res; 2017 Jan; 113(1):61-69. PubMed ID: 28028070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quercitrin inhibits platelet activation in arterial thrombosis.
    Oh TW; Do HJ; Jeon JH; Kim K
    Phytomedicine; 2021 Jan; 80():153363. PubMed ID: 33070081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clopidogrel-insensitive inducible pool of P2Y12 receptors contributes to thrombus formation: inhibition by elinogrel, a direct-acting, reversible P2Y12 antagonist.
    Haberstock-Debic H; Andre P; Mills S; Phillips DR; Conley PB
    J Pharmacol Exp Ther; 2011 Oct; 339(1):54-61. PubMed ID: 21730013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 12(S)-HETrE, a 12-Lipoxygenase Oxylipin of Dihomo-γ-Linolenic Acid, Inhibits Thrombosis via Gαs Signaling in Platelets.
    Yeung J; Tourdot BE; Adili R; Green AR; Freedman CJ; Fernandez-Perez P; Yu J; Holman TR; Holinstat M
    Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2068-77. PubMed ID: 27470510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The platelet P2 receptors as molecular targets for old and new antiplatelet drugs.
    Gachet C
    Pharmacol Ther; 2005 Nov; 108(2):180-92. PubMed ID: 15955565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.
    Foster CJ; Prosser DM; Agans JM; Zhai Y; Smith MD; Lachowicz JE; Zhang FL; Gustafson E; Monsma FJ; Wiekowski MT; Abbondanzo SJ; Cook DN; Bayne ML; Lira SA; Chintala MS
    J Clin Invest; 2001 Jun; 107(12):1591-8. PubMed ID: 11413167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thromboxane A(2) synthase inhibitor enhanced antithrombotic efficacy of GPIIb-IIIa receptor antagonist without increasing bleeding.
    Kawano KI; Hokamura K; Kondo K; Ikeda Y; Suzuki Y; Umemura K
    Eur J Pharmacol; 2001 Apr; 417(3):217-22. PubMed ID: 11334853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of P2Y
    Paul DS; Blatt TN; Schug WJ; Clark EG; Kawano T; Mackman N; Murcia S; Poe KO; Mwiza JMN; Harden TK; Bergmeier W; Nicholas RA
    J Thromb Haemost; 2023 Jul; 21(7):1891-1902. PubMed ID: 36958516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Thymidine Phosphorylase With Tipiracil Hydrochloride Attenuates Thrombosis Without Increasing Risk of Bleeding in Mice.
    Belcher A; Zulfiker AHM; Li OQ; Yue H; Gupta AS; Li W
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):668-682. PubMed ID: 33297751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis.
    Momi S; Caracchini R; Falcinelli E; Evangelista S; Gresele P
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):820-9. PubMed ID: 24558107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.